COVID19 — Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
Citation(s)
Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care". J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
Baghizadeh Fini M What dentists need to know about COVID-19. Oral Oncol. 2020 Jun;105:104741. doi: 10.1016/j.oraloncology.2020.104741. Epub 2020 Apr 28. Review.
Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 2012 Dec;83(12):1449-54. doi: 10.1902/jop.2012.110664. Epub 2012 Mar 16.
Ge ZY, Yang LM, Xia JJ, Fu XH, Zhang YZ Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ Sci B. 2020 May;21(5):361-368. doi: 10.1631/jzus.B2010010. Epub 2020 Mar 16. Review.
Harrel SK, Molinari J Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc. 2004 Apr;135(4):429-37. Review.
Izzetti R, Nisi M, Gabriele M, Graziani F COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy. J Dent Res. 2020 Aug;99(9):1030-1038. doi: 10.1177/0022034520920580. Epub 2020 Apr 17. Review.
Kirk-Bayley, J , Challacombe, S., Sunkaraneni, V. & Combes, J. The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Protect Healthcare Workers and Reduce Cross Infection. SSRN Electron. J.(2020) doi:10.2139/ssrn.3563092
Pfefferle, S et al.Low and high infection dose transmission of SARS-CoV-2 in the first COVID-19 clusters in Northern Germany. medRxiv (2020) doi:10.1101/2020.06.11.20127332
Statkute, E , Rubina, A., O'Donnell, V., Thomas, D., & Stanton, R. The Virucidal Efficacy of Oral Rinse Components Against SARS-CoV-2 In Vitro. BiorXiv. doi.org/10.1101/2020.11.13.381079
Tonetti et al J Periodontol 89 (Suppl 1): S159-S172 [2018]; Trombelli et al. J Periodontol 89 (Suppl 1): S46-S73 [2018]; Chapple et al. J Periodontol 89 (Suppl 1) S74-S84 [2018]
Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
